Skip to content

Author

M. DerSarkissian

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Characteristics and outcomes of patients with advanced or metastatic non-small cell lung cancer harboring a HER2-activating mutation: a real-world retrospective cohort study using a US clinico-genomic database.

INTRODUCTION Human epidermal growth factor receptor 2 (HER2/ERBB2) mutated non-small cell lung cancer (NSCLC) is associated with poor prognosis and limited treatment options. METHODS This retrospective cohort study used electronic health records from US academic and community cancer centers to describe characteristic...

Xiu-Ning Le, C. Chouaid, F. López-Ríos et al. · 0 citations
Open access Oct 2026

Complicated Urinary Tract Infections Caused by Fluoroquinolone-Non-Susceptible/Trimethoprim-Sulfamethoxazole-Resistant Extended-Spectrum β-Lactamase-Producing Enterobacterales: Patient Characteristics, Resistance Phenotypes, Treatment Patterns, and Clinical Outcomes.

INTRODUCTION Patients with complicated urinary tract infections (cUTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacterales (ESBL-E) not susceptible (NS) to fluoroquinolones (FQ-NS) or resistant (R) to trimethoprim-sulfamethoxazole (TMP/SMX-R) have few effective oral treatment options. METHODS D...

Ryan K. Shields, A. Ackerman, Myriam Drysdale et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.